Researchers from the Stern Stroke Center at Montefiore Medical Center published trial results this week showing that stroke survivors were twice as likely to take anticoagulants when using an artificial intelligence platform compared to patients receiving standard therapies. The AI platform, AiCure, features software algorithms on smartphones that confirm patient identify, medication and drug ingestion. […]
Big Data
Boston Scientific’s Connected Patient Challenge: Big data takes center stage
In partnership with Google and Medstro, Boston Scientific featured companies tackling healthcare with big data at its 2nd annual Connected Patient Challenge. Big data, artificial intelligence and patient-engagement technologies were among the systems featured at yesterday’s Connected Patient Challenge hosted by Boston Scientific (NYSE:BSX) at Google’s Cambridge, Mass. facility. The Shark Tank–style event featured 6 companies competing […]
7 medtech stories we missed this week: March 3, 2017
Several clinical study results were published this week, while other companies reached distribution deals. Here are 7 medtech stories we missed this week but were still worth mentioning. 1. Health Canada approves Ventripoint’s complete heart analysis system for 2D ultrasounds Ventripoint Diagnostics received a license from Health Canada for its new VMS-Plus machine and the 4-chamber […]
Boston Scientific’s Connected Patient contest finalists focus on data
Boston Scientific (NYSE:BSX) today announced the 6 finalists in its 2nd annual Connected Patient Challenge competition, which challenges groups to use big data to create actionable intelligence to increase patient care and healthcare efficiency. The challenge, created in collaboration with physician interactive platform Medstro and supported by Google (NSDQ:GOOG), had 46 contestants worldwide with concepts. Entries […]
GCMI and BD to support medtech startups in Southeast U.S.
The Global Center for Medical Innovation has partnered with Becton, Dickinson and Co. (BD) to support the launch of the GCMI Medtech Accelerator. “Too many medtech startups fail unnecessarily due to a lack of bridge, or seed funding, required to advance far enough in the commercialization process to attract investment by a larger device company,” […]
Medtech IoT: We need to talk about what is happening in middleware
Middleware could be the key when it comes to discussing how the Internet of Things is going to succeed in medtech. In the most simplistic definition, middleware is software that acts as a bridge between an operating system or database and applications, especially on a network. For example, if a bedside monitor is designed to […]
S&P: Medtech outlook stable, even after downgrades
The outlook for investment-grade medical device companies remains stable even after a 3-year streak of 9 consecutive downgrades, according to a new report from S&P. The downgrade of investment-grade medical device companies was mostly caused by debt-financed mergers and acquisitions, according to S&P. Factors like changes in operating performance trends and financial policy also contributed […]
Healthcare IT funding hits record $5.1 billion
Global funding for healthcare information technology and digital health companies hit record levels last year, according to the latest annual report from Austin, Texas–based Mercom Capital Group. There were a record 622 deals worth $5.1 billion in 2016, up from 574 deals worth $4.6 billion in 2015, according to Mercom Capital Group. The amounts involve […]
Counterfeit prescription drug tracker raises $52m
TraceLink Inc. said yesterday that it raised $51.5 million in a Series C financing round, bringing its total raised to $77 million. The round was led by Goldman Sachs Growth Equity, joining FirstMark Capital, Volition Capital and F-Prime Capital. TraceLink developed a cloud-based global network of manufacturers, distributors, pharmacies and healthcare professionals. The firm’s system enables […]
Celgene invests in GNS
Celgene (NSDQ:CELG) said this week that it has made another investment in GNS Healthcare and inked a deal with the bioanalytics firm for its “Reverse Engineering and Forward Simulation” software. GNS’s software analyzes health data, including electronic health records, pharmacy claims and genomic sequences, and uses machine learning to answer questions in healthcare. The multi-year agreement […]
Broad Institute, IBM Watson launch initiative to study cancer drug resistance
IBM Watson Health (NYSE:IBM) and the Broad Institute said today that they’ve launched a research initiative with the hopes of discovering the basis for cancer drug resistance. The 5 year, $50 million collaboration will study the genetic information of thousands of drug resistant tumors and use Watson’s machine learning methods to help understand the underlying […]